A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-04
- Last Posted Date
- 2011-11-02
- Lead Sponsor
- Napp Pharmaceuticals Limited
- Target Recruit Count
- 247
- Registration Number
- NCT00784810
Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly
- First Posted Date
- 2006-05-10
- Last Posted Date
- 2011-06-14
- Lead Sponsor
- Napp Pharmaceuticals Limited
- Target Recruit Count
- 219
- Registration Number
- NCT00324038
- Locations
- 🇬🇧
Napp Pharmaceuticals Ltd, Cambridge, United Kingdom
© Copyright 2024. All Rights Reserved by MedPath